FDA Approves New Treatment Option For Glioma

In an era when targeted therapies are often effective against multiple types of cancer, the U.S. Food and Drug Administration’s accelerated approval of a two-drug therapy for solid tumors carrying a specific mutation in the BRAF gene is a prime example of this trend. For patients with glioma brain cancer that harbors the mutation, the … Read more

Specially Equipped Natural Killer Cells Show Promise Against Form of AML

CAR T cells’ superpower is to identify cancer-related targets on the surface of tumor cells and order an attack on those cells. But they lack anything resembling X-ray vision to detect nefarious protein targets within tumor cells. That shortfall has limited their effectiveness in diseases like acute myelogenous leukemia (AML), in which tumor cells display few surface … Read more

Advances in Myeloma, Breast Cancer, and Clinical Trials Equity: A Dana-Farber Research Update

Results of several phase 3 trials and dozens of other studies led by Dana-Farber researchers were presented online and in person June 3-7 at the 2022 Annual Meeting of the American Society of Clinical Oncology (ASCO), the world’s largest clinical cancer research meeting. Some of the research reports presented by Dana-Farber investigators include: Improved progression-free … Read more

Stem Cell Transplant Gives MDS Patient a Second Chance at Life

Every year, Nancy Demers celebrates two birthdays. The first marks the day she was born: August 6, 1943. The second — March 20, 2015 — is the day the then-71-year-old Connecticut resident received a stem cell transplant at Dana-Farber Brigham Cancer Center and the start of a healthy new life. Eighteen months prior, in September … Read more

Patient with Lung Cancer Participates in ‘Practice-Changing’ Immunotherapy Research

Every school day, when Mike James walks into work at Boston Adult Technical Academy (BATA), he sees an inspiring sign painted by the students: Together, We Can. That philosophy lifted James up after he was diagnosed with early-stage non-small cell lung cancer in August 2019. James leaned on his support network of coworkers, his family, … Read more

Young Colorectal Cancer Patient Works with Care Team to Reduce Risk of Recurrence

At 43, Erick Eigner was leading a healthy and fulfilling life: spending time with family, working in marketing at Microsoft, and hitting the gym six days a week. Cancer was the last thing he was thinking about when he went to the doctor for a physical and mentioned some concerns he had about swallowing. The … Read more

CNS Lymphoma Survivor Stays on Call with Immunotherapy

Stephan Bunker has learned to be prepared for anything during a half-century protecting others as a soldier, volunteer firefighter, law enforcement official, and director of 911 dispatchers for the state of Maine. So when Bunker was the one facing an emergency — a diagnosis of a brain cancer known as primary central nervous system (CNS) … Read more

Researchers Use CRISPR To Build A Human Melanoma Model From Scratch

This post was adapted from a Broad Institute post by Allessandra DiCorato. Over the last two decades, researchers have discovered thousands of genetic mutations in cancer. But understanding how they affect the growth and spread of tumors in the body remains challenging because each patient’s tumor can have many different mutations.  Now, scientists have used … Read more

What is Cardiac Angiosarcoma?

One of the rarest of rare cancers, cardiac angiosarcoma is a tumor of the heart that has gained some notoriety because it caused the death of fashion designer Virgil Abloh in 2021 at the age of only 41. Abloh, the artistic director of Louis Vuitton menswear and the founder of his own brand, Off-White, lived … Read more

Newly Identified Regulator in Prostate Cancer Cells Could Serve as Drug Target for Advanced Tumors

Treating advanced prostate cancer typically involves surgery — to reduce levels of testosterone, which fuels the growth of tumors — or giving drugs that blockade the androgen receptor (AR), which responds to testosterone by stimulating cancer-growth genes. While these measures can keep the disease at bay initially, resistance almost always occurs as the androgen receptor … Read more

Earlier Use of CAR T-Cell Therapy Approved for Relapsed Large B-cell Lymphoma Patients

Patients with large B-cell lymphoma (LBCL) who did not respond to initial treatment or relapsed within a year may now receive the CAR T-cell product axicabtagene ciloleucel (Yescarta) as a second-line therapy, following approval by the U.S. Food and Drug Administration (FDA) based on results of a recent clinical trial. Until now, the standard of … Read more

Seeking Stem Cell Transplant, Basketball Expert Makes Slam Dunk Decision

As an economist specializing in statistical analysis, Dan Rosenbaum has done everything from help the federal government use more evidence in its decision-making to assist several National Basketball Association (NBA) teams in finding and signing the best players. Research and number-crunching are his expertise, so when Rosenbaum learned he needed a life-saving stem cell transplant … Read more

Study Calls for Fresh Look at Disparities in Breast Cancer Treatment

For as long as researchers have known about disparities in cancer treatment, they’ve sought to explain them. Do some patients receive different care than others because of race, age, wealth, or gender? Or does the region where they receive treatment matter most? Only by answering questions like these can researchers know where to focus their … Read more

What is a Stereotactic Breast Biopsy?

An annual physical or mammogram can help detect lumps or abnormalities in the breast, but these exams cannot tell whether a growth is cancerous or noncancerous. If a breast lump or abnormality is found in your breast, your doctor may advise you to have a breast biopsy. A stereotactic breast biopsy is a kind of … Read more